eli lilly & co (LLY:New York)
Earnings & Estimates Summary - ELI LILLY & CO (LLY)
2013 revenues at Eli Lilly and Company totaled $23.1B USD, while annual earnings equaled $4.15 per share.
Quarterly Earnings & Estimates - ELI LILLY & CO (LLY)
Eli Lilly and Company's Quarterly Earnings
Eli Lilly and Company reported 2nd quarter 2014 earnings of $0.68 per share on 07/26/2014.
Annual Earnings & Estimates - ELI LILLY & CO (LLY)
Eli Lilly and Company's Annual Earnings
Eli Lilly and Company reported annual 2013 earnings of $4.15 per share on 02/1/2014.
Quarterly Revenues - ELI LILLY & CO (LLY)
Eli Lilly and Company's Quarterly Revenues
Eli Lilly and Company had 2nd quarter 2014 revenues of $4.9B USD. This bettered the $4.9B USD consensus of the 12 analysts covering the company. This was -16.8% below the prior year's 2nd quarter results.
Annual Revenues - ELI LILLY & CO (LLY)
Eli Lilly and Company's Annual Revenues
Eli Lilly and Company had revenues for the full year 2013 of $23.1B USD. This was 2.3% above the prior year's results.
|Abbott Laboratories||$43.89 USD||+0.03|
|AbbVie Inc||$62.42 USD||-0.01|
|AstraZeneca PLC||4,702 GBp||-32.00|
|Novo Nordisk A/S||kr297.20 DKK||+4.20|
|Teva Pharmaceutical Industries Ltd||$58.66 USD||-1.22|
|View Industry Companies|